Drug · DIN 02460424
FIASP
3 ML PREFILLED PEN
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 24, 2026; first marketed March 3, 2017.
- Drug Identification Number (DIN)
- 02460424
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin aspart A10AB05
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN ASPART | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 6, 2017: NOC 18839New Drug Submission (NDS)
Other DINs named FIASP
- DIN 02460408 · Marketed
- DIN 02460416 · Marketed